Published: May 13, 2021
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) Sunshine Biopharma, Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs, announced that it has filed its 2021 first quarter report. The Report shows that the Company had Cash & Cash Equivalents of $1,796,596 as of March 31, 2021, the period end.
The following is a summary of the Report highlights:
On January 26, 2021, the Company received a Notice of Allowance from the Canadian Intellectual Property Office for a new patent application covering Adva-27a. The newly issued patent contains new subject matter and extends the proprietary protection of Adva-27a in Canada until 2033.
Opinion: A Faulty System And Beloved Ranjana s Death Opinion: A Faulty System And Beloved Ranjana s Death
Updated: May 12, 2021 12:10 pm IST
On a really hot summer day, in May 1980, a group of women were marching down a small, dusty lane in a workers colony in Faridabad, enthusiastically shouting slogans as part of a campaign against dowry. They were undeterred that there was not a person to be seen except when a window, shuttered to keep out the searing heat, would open slightly through the march, and a woman would peak her head out to see what the noisy slogans were about. Ranjana and I paused, looked at each other and laughed out aloud with the same thought in our minds - a thought which she voiced. Only crazy women and Communists out in the noon day sun!
Sunshine Biopharma Upgrades COVID-19 Provisional Patent Application to Full PCT Application streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
RB Capital Increases Investment in Sunshine Biopharma
April 22, 2021 08:00 ET | Source: Sunshine Biopharma Inc. Sunshine Biopharma Inc. Montreal, Quebec, CANADA
MONTREAL, April 22, 2021 (GLOBE NEWSWIRE) Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that RB Capital has injected an additional investment of $500,000 to augment the Company’s Coronavirus drug development program. In addition, RB Capital has provided the Company with assurances that it will continue to provide funding over the next 30 days for the Company’s other R&D activities, including Ada-27a anticancer drug.
Sunshine Biopharma’s CFO, Camille Sebaaly stated, “We are very pleased to continue our relationship with RB Capital as long-term investor in the Company. They truly understand our vision and are prepared to help us
COVID-19 News 10:29 pm
There are currently 21 COVID-19 positive inpatients at Mount Nittany Medical Center. This according to Officials who say those patients range from ages 31 to 86, with 118 COVID related admissions and an average daily census of 25 COVID positive inpatients so far this month.
By comparison, there was an average daily census of 18 COVID positive inpatients in March with 124 COVID related admissions. They say this months numbers are the highest they’ve seen since January, following the Holiday Season.
The National Institutes of Health says it’s testing a new, experimental drug in severely ill Coronavirus patients. The Phase 3 Clinical Trial includes patients hospitalized with life-threatening cases of COVID-19, including those with Acute Respiratory Failure. The trial will test the drug Zyesami and the antiviral Remdesivir both alone and in combination. The drugs will be tested for their safety and efficacy in hospitalized COVID-19 patients